Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Clinical Diagnostics Insider
(formerly Diagnostic Testing and Emerging Technologies)
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
CMS Final Fee Schedule Will Impact Patient Access to Laboratories: COLA
From - Diagnostic Testing & Emerging Technologies
The CMS Final Fee Schedule will hurt patient access to clinical laboratories, says the lab accreditation bureau COLA…
Bilirubin as a Predictor of Neonatal Jaundice
...
Already a member? Log in here
Innovation in Urine Collection Cuts Contamination, Retesting
...
Already a member? Log in here
New Speed Record Set for Genome Analysis
...
Already a member? Log in here
Malpractice Lawsuit Calls Out Lack of Genetic Counseling
From - Diagnostic Testing & Emerging Technologies
A 36-year-old Oregon woman filed a $1.8 million medical malpractice lawsuit against her doctors and a southwest Oregon medical center for…
CMS Ignores Flawed Processes, Finalizes 2018 PAMA Pricing; Labs Need to Take Immediate Action to Offset Impending Lean Times
By Kyle Fetter bio
The final 2018 clinical laboratory fee schedule (CLFS) is out, and it is evident that the argument that the Centers for Medicare & Medicaid Services (CMS) PAMA process was…
New Evidence Suggests Frequent Lipid Monitoring May be Unnecessary
...
Already a member? Log in here
Federal Guidelines for Workplace Drug Testing Add Opioids
From - Diagnostic Testing & Emerging Technologies
As of Oct. 1, new federal mandatory guidelines for workplace drug testing expanded to include the authority to test for…
